- Labeler Index
- Hospira, Inc.
- 61703-319
- NDC Crossover: 61703-319 Cytarabine
NDC Crossover 61703-319 Cytarabine
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Cytarabine
Explore similar products and medications to NDC 61703-319 Cytarabine a human prescription drug with other products crossover matching the same product name (Cytarabine) or generic name (Cytarabine), and the same administration route (intrathecal; intravenous; subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
25021-223 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
63323-120 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
68083-337 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Gland Pharma Limited | Human Prescription Drug |
71288-109 | Cytarabine | Cytarabine | Injection, Solution | Intrathecal; Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | Human Prescription Drug |